Cite
Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: international development of a glucocorticoid treatment–specific patient-reported outcome measure.
MLA
Bridgewater, Susan, et al. “Measuring the Impact of Steroid Therapy on Health-Related Quality of Life in Patients with Rheumatic Diseases: International Development of a Glucocorticoid Treatment–specific Patient-Reported Outcome Measure.” Rheumatology, vol. 62, no. 11, Nov. 2023, pp. 3565–75. EBSCOhost, https://doi.org/10.1093/rheumatology/kead081.
APA
Bridgewater, S., Shepherd, M. A., Dawson, J., Richards, P., Silverthorne, C., Ndosi, M., Almeida, C., Black, R. J., Cheah, J. T. L., Dures, E., Ghosh, N., Hoon, E. A., Lyne, S., Navarro-Millan, I., Pearce-Fisher, D., Ruediger, C., Tieu, J., Yip, K., Mackie, S. L., & Goodman, S. (2023). Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: international development of a glucocorticoid treatment–specific patient-reported outcome measure. Rheumatology, 62(11), 3565–3575. https://doi.org/10.1093/rheumatology/kead081
Chicago
Bridgewater, Susan, Michael A Shepherd, Jill Dawson, Pamela Richards, Christine Silverthorne, Mwidimi Ndosi, Celia Almeida, et al. 2023. “Measuring the Impact of Steroid Therapy on Health-Related Quality of Life in Patients with Rheumatic Diseases: International Development of a Glucocorticoid Treatment–specific Patient-Reported Outcome Measure.” Rheumatology 62 (11): 3565–75. doi:10.1093/rheumatology/kead081.